Infinity Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Infinity Pharmaceuticals Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Infinity Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Infinity Pharmaceuticals Inc.

Back to companies

Infinity Pharmaceuticals Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Infinity Pharmaceuticals Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
US20230364097A1 Application Treatment of cancers using pi3 kinase isoform modulators C12Q1/6886; C12Q2600/156; C12Q2600/158; A61K31/519; A61K31/52; A61K39/39558; A61K45/06; C07D473/34; C07K16/2887 November 16, 2023
ZA201808537B Grant Combination therapies A61K2039/505; A61K2300/00; A61K31/497; A61K31/52; A61K39/395; A61K39/39566; A61K45/06; A61P35/00; C07K16/2803; C07K16/2818; C07K2317/21; C07K2317/24 October 25, 2023
EP4259149A1 Application Éganélisib destiné à être utilisé dans le traitement d'un cancer pd-l1 négatif A61K31/337; A61K31/519; A61K39/3955; A61P35/00 October 18, 2023
NO347310B1 Grant Cyklopaminanaloger A61K31/17; A61K31/196; A61K31/198; A61K31/4355; A61K31/454; A61K31/4741; A61K31/4745; A61K31/4747; A61K31/519; A61K31/56; A61K31/573; A61K31/58; A61K31/664; A61K31/69; A61K31/704; A61K31/7068; A61K31/7076; A61K38/21; A61K45/06; A61K9/0014; A61N5/10; A61P35/00; A61P35/02; A61P35/04; A61P43/00; C07D307/94; C07D471/04; C07D471/10; C07D491/04; C07D491/048; C07D491/10; C07D491/107; C07J69/00 September 11, 2023
NZ724368A Application Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders A61K2039/505; A61K2300/00; A61K31/337; A61K31/427; A61K31/437; A61K31/4725; A61K31/495; A61K31/497; A61K31/506; A61K31/517; A61K31/519; A61K31/5377; A61K39/0005; A61K39/39533; A61K39/39558; A61K39/39566; A61K45/06; A61P1/04; A61P11/00; A61P11/06; A61P17/00; A61P17/06; A61P19/02; A61P19/08; A61P19/10; A61P21/00; A61P25/00; A61P29/00; A61P3/12; A61P35/00; A61P35/02; A61P37/02; A61P43/00; A61P9/12; C07K16/2827; Y02A50/30 July 28, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer